Announcements for this section should be submitted in the correct format at least 3 months before the required date of publication.This list is provided as a service to readers;inclusion does not imply endorsement by the HBPD INT.

Section editor

Shui-Ying Lei

Email:hbpdje@gmail.com

June

Pancreatic cancer:progress and challenges

June 18-21,2012; Hyatt Regency Lake Tahoe,Lake Tahoe,NV,USA

The co-chairpersons of the conference are Daniel D.Von Hoff,Translational Genomics Research Institute,Phoenix,AZ; Dafna Bar-Sagi,New York University School of Medicine,New York,NY; Chi Van Dang,Abramson Cancer Center,University of Pennsylvania,Philadelphia,PA; David A.Tuveson,Cancer Research UK,Cambridge Research Institute,Cambridge,England.For more information,please visit:http://www.aacr.org/home/scientists/meetings-workshops/special- conferences/ pancreatic-cancerprogress-and-challenges.aspx.

14th international symposium on viral hepatitis and liver disease

June 22-25,2012; Shanghai International Convention Center,Shanghai,China

The symposium is organized by Chinese Academy of Engineering and Shanghai Municipal Government,hosted by Division of Medicine and Health,Chinese Academy of Engineering,Shanghai Medical School of Fudan University,Shanghai Consulting & Academic Activities Center for Academicians of Chinese Academy of Engineering; and co-organized by Chinese Medical Association (Society of Hepatology,Society of Infectious Diseases,Society of Virology),Chinese Society of Microbiology,Chinese Center for Disease Control and Prevention (CDC).It is supported by Ministry of Health of China,Ministry of Science and Technology of China,Ministry of Education of China and National Natural Science Foundation of China.The 14th ISVHLD will commemorate progress made in the globalfight against viral hepatitis and liver disease and focus on the key future challenges.The ISVHLD are dedicated to bringing together outstanding clinical and basic researchers in viral hepatitis from around the world to provide summary updates on advances in the understanding,diagnosis,prevention,control,and treatment of allfive forms of viral hepatitis.The meeting also provides a venue for reviewing the success of public health measures taken to control and prevent viral hepatitis.An important element in the ISVHLD is the inclusion of clinicians,investigators,and public health experts from all areas of the world,including developing nations where viral hepatitis contributes considerably to morbidity and mortality.The purpose is to provide stimulus for future researches and collaborations that promote control of viral hepatitis worldwide.For more information,please contact:International,Cosoman Limited,9/F.,New Hennessy Tower,263 Hennessy Road,Wanchai,Hong Kong.Tel:+852 2827 2090; Fax:+852 2827 2220; Email:info@isvhld2012.org; or China,YiZhong Events Promotion Service Co.,Ltd.,Room 307,560 Shengxia Road,Shanghai 201210,China.Tel:86-21-6859-7000; Fax:86-21-6859-7800; Email:info@isvhld2012.org.Website:http://www.isvhld2012.org.

September

The 7th Chinese conference on oncology & 11th cross-strait academic conference on oncology

September 6-9,2012; Beijing,China

Topics include oncology related pathology,basic research,surgical and internal therapy,radiotherapy,biology therapy,imaging,intervention therapy,nursing,general therapy and treatment for ache.For more information,please contact:Ke Gong,Bin Zhu,Education Center,Beijing Shijitan Hospital,Capital Medical University,10 Yangfangdian Tieyi Road,Haidian Area,Beijing 100038,China.Tel:86-10-63926335,or 63926989; Fax:86-10-63926989; Email:zwh@cco2012.org.Website:http://www.cco2012.org.

October

17th world congress on advances in oncology and 15th international symposium on molecular medicine

October 11-13,2012; Hotel Creta Maris Resort,Hersonissos,Crete,Greece

The congress is organized by the International Journal of Oncology,Oncology Reports,International Journal of Molecular Medicine,Molecular Medicine Reports,Experimental and Therapeutic Medicine and Oncology Letters.For registration and further information,please contact:Professor D.A.Spandidos,10 Vriaxidos Street,Athens 11634,Greece.Tel:30-210-722-7809; Fax:30-210-725-2922; Email:conference@spandidos-publications.com.Website:http://www.spandidos-publications.com.

20th united European gastroenterology week

October 20-24,2012; Amsterdam,Netherlands

The congress is organized by the United European Gastroenterology Federation.For more information,please contact:UEGF Secretariat,Wienerbergstr.11/12A,1100 Vienna,Austria.Tel:+43-1-997-16-39; Fax:+43-1-997-16-39-10; Email:office@uegf.org.Website:www.uegf.org.

13th Asia-Pacific congress on clinical microbiology and infection

October 25-28,2012; Beijing,China

The congress is hosted by Asia-Pacific Society of Clinical Microbiology and Infection (APSCMI,formerly WPSC).The chairman of this congress is Prof.Lan-Juan Li,Zhejiang University School of Medicine,Hangzhou,China.The congress is to provide the channels to demonstrate and share the progress that all specialists have achieved,link resources in chemotherapy and infectious diseases.For more information,please contact:Congress Secretariat(China),Beijing MedConference Service Co.,Ltd.,Ms.Xiao-Xue Bian,Room 510,B tower,Free Town Center,No.58,Dongsanhuan Rd.,Chaoyang District,Beijing 100022,China.Tel:86-10-67122288ext274; Fax:86-10-67160676;Email:bianxiaoxue@mpco.cn.Website:http://www.apccmi 2012.org/index.html.

November

24th EORTC-NCI-AACR symposium on molecular targets and cancer therapeutics

November 6-9,2012; Dublin,Ireland

The 24th EORTC-NCI-AACR symposium on molecular targets and cancer therapeutics will take place from November 06-09 2012 at Dublin,Ireland.Hosted by the European Organisation for Research and Treatment of Cancer,the National Cancer Institute and the American Association for Cancer Research,the 2012 symposium will bring together over 2000 academics,scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development,target selection and the impact of new discoveries in molecular biology.The deadline of abstract submission is Wednesday,June 27,2012; the deadline for early registration:Monday,June 25,2012.For more information,please visit:http://www.ecco-org.eu/Home/Conferences/Conferences/EORTC_NCI_AACR%202012.aspx.

Post-GWAS Horizons in molecular epidemiology:digging deeper into the environment

November 11-14,2012; Westin Diplomat Resort,Hollywood,FL,USA

Genome-wide association studies (GWAS) have brought forth a vast amount of information on genetic risk factors for cancer.The conference will showcase and discuss new areas of research in molecular epidemiology,focusing on the integration of novel measures of internal and external environmental factors in consortia and genetic studies.Research findings will be presented to illustrate the vast potential within the context of epidemiologic studies in a post-GWAS context to further the prevention of cancer and elucidate mechanisms of carcinogenesis.Large-scale publicly-available research resources will be highlighted and their "rules to play" discussed.Late-breaking findings from genomics,epigenomics,and proteomics in epidemiologic studies will be presented with a view to discern the most promising strategies with the greatest public health impact.For more information,please visit:http://www.aacr.org/home/scientists/meetings--workshops/special-conferences/post-gwas-horizons-in-molecularepidemiology.aspx.

Translational cancer research for basic scientists

November 26-December 1,2012; Hilton Boston Back Bay,Boston,MA,USA

This workshop is hosted in close collaboration with the Dana-Farber Cancer Institute/Harvard Cancer Center,comprised of Beth Israel Deaconess Medical Center,Brigham and Women’s Hospital,Children’s Hospital Boston,Dana-Farber Cancer Institute,Harvard Medical School,Harvard School of Public Health and Massachusetts General Hospital.The Translational Cancer Research for Basic Scientists Workshop will provide basic research scientists with a better understanding of translational research,teach them how to adapt their research for maximum clinical impact,and help them transition into a new career in translational cancer medicine.This innovative workshop addresses many aspects of translational research including leading multidisciplinary teams,working collaboratively and effectively with industry partners,recognizing the unique needs and environment of the clinic and clinical laboratories,dealing with the regulatory and compliance issues in translational science,and understanding the perspective of the patient in order to place research questions into a broader context.During the course of the week,attendees will gain perspective and background knowledge of the disease from translational scientists in academia and industry,clinicians and patients,while learning about the latest methods and approaches in cutting-edge translational cancer research.For further information,please contact Lyngine Calizo,Ph.D.,program administrator,at (215) 446-7265 or lyngine.calizo@aacr.org.